You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 14, 2025

Details for Patent: 8,822,637


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,822,637
Title:Somatostatin analogues
Abstract: The invention provides cyclo[{4-(NH.sub.2--C.sub.2H.sub.4--NH--CO--O-)Pro}-Phg-DTrp-Lys-Tyr(4-Be- nzyl)-Phe], optionally in protected form, or a pharmaceutically acceptable salt or complex thereof, which has interesting pharmaceutical properties.
Inventor(s): Albert; Rainer (Basel, CH), Bauer; Wilfried (Lampenberg, CH), Bodmer; David (Klingnau, CH), Bruns; Christian (Freiburg, DE), Felner; Ivo (Reinach, CH), Hellstern; Heribert (Heitersheim, DE), Lewis; Ian (Riehen, CH), Meisenbach; Mark (Durmenach, FR), Weckbecker; Gisbert (Biel-Benken, CH), Wietfeld; Bernhard (Efringen-Kirschen, DE)
Assignee: Novartis AG (Basel, CH)
Application Number:13/048,932
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 8,822,637: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for both patent holders and those seeking to navigate the intellectual property landscape. This article will delve into the details of United States Patent 8,822,637, exploring its claims, scope, and the broader patent landscape it inhabits.

Patent Overview

United States Patent 8,822,637, hereafter referred to as the '637 patent, is a utility patent granted by the United States Patent and Trademark Office (USPTO). To analyze this patent, one must first identify its key components, including the invention's description, claims, and any relevant prior art.

Invention Description

The '637 patent describes an invention that addresses a specific problem or need within its field. Understanding the invention's purpose and how it operates is essential for grasping the patent's scope. This typically involves reviewing the patent's specification, which includes detailed descriptions, drawings, and examples of the invention.

Claims Analysis

Independent Claims

The independent claims of the '637 patent define the broadest scope of the invention. These claims are critical because they set the boundaries of what is considered novel and non-obvious. Independent claims are typically more general and encompass the core aspects of the invention[4].

Dependent Claims

Dependent claims, on the other hand, are narrower and build upon the independent claims. They often add specific details or limitations to the independent claims, providing additional protection for specific embodiments of the invention. Analyzing dependent claims helps in understanding the various aspects and variations of the invention that are protected[5].

Scope of Protection

The scope of protection for the '637 patent is determined by its claims. Here are some key points to consider:

Claim Construction

Claim construction involves interpreting the language of the claims to determine their meaning and scope. This process is crucial for understanding what is protected and what is not. Courts and the USPTO use various tools and principles to construct claims, ensuring that the scope is clear and consistent with the invention's description[5].

Prior Art and Novelty

To ensure the '637 patent is valid, it must be novel and non-obvious over the prior art. Prior art includes all publicly available information and previous patents related to the invention. Analyzing prior art helps in understanding whether the '637 patent introduces new and innovative elements that were not previously known or obvious[4].

Patent Landscape Analysis

Patent Family

The '637 patent may be part of a larger patent family, which includes other related patents such as continuations, continuations-in-part, and divisional patents. Understanding the patent family is essential for identifying all relevant patents and their interrelationships, similar to the analysis in the Cellect case where multiple patents were part of the same family[1].

Claim Coverage Matrix

Using a Claim Coverage Matrix, as described in patent analytics services, can help categorize the patents and claims by scope concepts. This tool is invaluable for filtering, searching, and analyzing large numbers of patent claims concurrently. It helps identify which patents and claims are actively protecting the intellectual property and where gaps or opportunities exist[3].

Competitor Patents

Analyzing competitor patents within the same field can provide insights into the competitive landscape. This involves searching databases such as those provided by the USPTO, European Patent Office (EPO), and other international intellectual property offices to identify similar inventions and their claims[4].

Patent Term and Adjustments

The patent term of the '637 patent, typically 20 years from the earliest filing date, can be affected by various factors such as Patent Term Adjustments (PTA) for USPTO delays during prosecution. Understanding these adjustments, as seen in the Cellect case, is crucial for determining the actual expiration date of the patent and any implications for obviousness-type double patenting (ODP) analyses[1].

Obviousness-Type Double Patenting (ODP)

ODP is a doctrine that prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to PTA or other adjustments. Ensuring that ODP analyses are performed correctly, considering any PTA or terminal disclaimers, is vital for maintaining the validity of the '637 patent[1].

Practical Applications and Design Opportunities

Using tools like Claim Charts, as part of patent analytics, can help engineers, scientists, and management review the patent coverage and identify gaps or future design opportunities. These charts make it easy to spot areas where claim coverage is lacking and highlight potential future directions for innovation[3].

Key Takeaways

  • Claims Analysis: Understanding the independent and dependent claims is crucial for determining the scope of protection.
  • Prior Art: Ensuring novelty and non-obviousness over prior art is essential for patent validity.
  • Patent Landscape: Analyzing the patent family and competitor patents provides a comprehensive view of the intellectual property landscape.
  • Patent Term: Understanding PTA and ODP is vital for determining the patent's expiration date and validity.
  • Practical Applications: Using patent analytics tools helps in identifying gaps and future design opportunities.

FAQs

Q: What is the significance of independent claims in a patent?

Independent claims define the broadest scope of the invention and set the boundaries of what is considered novel and non-obvious.

Q: How does Patent Term Adjustment (PTA) affect the patent term?

PTA can extend the patent term beyond the standard 20 years due to delays during prosecution, but it does not extend the term past the date of a terminal disclaimer.

Q: What is the purpose of a Claim Coverage Matrix?

A Claim Coverage Matrix helps categorize patents and claims by scope concepts, making it easier to filter, search, and analyze large numbers of patent claims concurrently.

Q: Why is it important to analyze competitor patents?

Analyzing competitor patents provides insights into the competitive landscape and helps identify similar inventions and their claims, which can inform strategic decisions.

Q: What is Obviousness-Type Double Patenting (ODP)?

ODP prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to PTA or other adjustments.

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit, August 28, 2023.
  2. Wilfried Bauer Inventions, Patents and Patent Applications - Justia.
  3. Patent Analytics - Schwegman, Lundberg & Woessner, P.A.
  4. Search for patents - USPTO.
  5. 35 USC 282: Presumption of validity; defenses - United States Code.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 8,822,637

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

Foreign Priority and PCT Information for Patent: 8,822,637

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0018891.2Aug 1, 2000

International Family Members for US Patent 8,822,637

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
European Patent Office 1307486 ⤷  Try for Free C300536 Netherlands ⤷  Try for Free
European Patent Office 1307486 ⤷  Try for Free 12C0041 France ⤷  Try for Free
European Patent Office 1307486 ⤷  Try for Free CA 2012 00024 Denmark ⤷  Try for Free
European Patent Office 1307486 ⤷  Try for Free 92024 Luxembourg ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 4 of 4 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.